Azitra (AZTR) Cash from Operations (2022 - 2026)
Azitra's (AZTR) quarterly Cash from Operations came in at 2477304.0 in Q1 2026, up 19.35% YoY from 2075622.38 in Q1 2025, and up 13.64% on a QoQ basis from 2868486.0 in Q4 2025.
Azitra (AZTR) Cash from Operations (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Cash from Operations data on file, last reported at 2477304.0 in Q1 2026.
- Quarterly Cash from Operations rose 19.35% year-over-year to 2477304.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10605542.0 (down 3.62% YoY) and the FY2025 annual result came in at 11200000.0, down 9.98% from the prior year.
- Cash from Operations improved to 2477304.0 in Q1 2026, from 2868486.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1304348.0 in Q1 2023 to a low of 3071762.0 in Q1 2025.
- A 5-year average of 2365418.87 and a median of 2475584.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations plunged 131.53% — and 2026, when it gained 19.35%.
- Tracing AZTR's Cash from Operations over 5 years: stood at 2172692.0 in 2022, then declined by 16.87% to 2539207.0 in 2023, then declined by 1.85% to 2586201.0 in 2024, then fell by 10.92% to 2868486.0 in 2025, then climbed by 13.64% to 2477304.0 in 2026.
- The last three Cash from Operations figures came in at 2477304.0 (Q1 2026), 2868486.0 (Q4 2025), and 2444716.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - | -3.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.30 Mn |
| Jun 30, 2026 | -3.30 Mn |
| Mar 31, 2026 | -2.48 Mn |
| Mar 31, 2026 | -2.48 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.44 Mn |
| Sep 30, 2025 | -2.44 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Mar 31, 2024 | -3.02 Mn |